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Abstract 
In the current study the ex vivo permeation of ropinirole hydrochloride (RH) across 
porcine buccal mucosa in the presence of three permeation enhancers namely; N-
trimethyl chitosan (TMC) (positively charged) a chitosan derivative, sulfobutyl ether-
β-cyclodextrin (SBE-β-CD) (negatively charged) and hydroxypropyl-β-cyclodextrin 
(HP-β-CD) (neutral), was investigated. Buccal permeation studies were conducted 
using Franz diffusion cells. Cumulative amounts of RH were plotted versus time. The 
presence of the permeation enhancers significantly increased the transport of the drug 
across the porcine buccal epithelium compared to its plain congener (RH solution). The 
rank order effect of the permeation enhancers for the transport of RH across buccal 
epithelium was TMC ≥ SBE-β-CD > HP-β-CD > RH solution. The presence of TMC 
increased 1.34 fold the transport of RH across buccal epithelium whereas an increase 
of 1.23 and 1.28 fold was reported in the presence of HP-β-CD and SBE-β-CD. Infrared 
spectroscopy (IR) was employed to investigate the interaction of permeation enhancers 
with the epithelial lipids of porcine buccal mucosa corroborating the permeation results. 
Finally light microscopy was performed to assess the histological changes in the 
porcine epithelium. Formation of vacuoles, spongiosis and acantholysis linear 
detachment and destruction of the epithelium resulted from the presence of the 
permeation enhancers. The data suggest that all enhancers tested, and particularly TMC, 
increase the transport of RH across buccal epithelium. 
 
Keywords:  ropinirole hydrochloride; Parkinson’s disease; buccal delivery; permeation 
enhancers. 
 
 
1. Introduction 
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The buccal route offers many advantages over conventional routes of drug delivery with 
an improved bioavailability at smaller doses than oral formulations due to the avoidance 
of degradation in the gastrointestinal tract and hepatic first-pass metabolism [1]. Drugs 
can reach the systemic circulation directly through the capillary vessels, bypassing the 
first-pass metabolism in the intestine and liver or avoiding inactivation in the stomach. 
These characteristics contribute to higher bioavailability parameters after 
administration of a smaller dose of the drug than in conventional oral formulations [2]. 
An approach to overcome the barrier properties of the buccal mucosa for drugs is the 
incorporation of chemical enhancers in the formulations [3, 4]. Bile salts, cyclodextrins 
and chitosan are commonly used enhancers. Methyl-β- and β-cyclodextrins have been 
previously evaluated for their potential enhancement effect on the buccal permeation 
of omeprazole [5]. Chitosan [6] and its derivatives [7, 8] have also showed a significant 
enhancing effect on permeation of drugs across the buccal mucosa.  
In an attempt to investigate the effect of charge to the transport rate of ropinirole 
hydrochloride (RH) and any effect at the ultrastructure of the tissue three permeation 
enhancers, namely N-trimethyl chitosan (positively charged) a chitosan derivative, 
sulfobutyl ether-β-cyclodextrin (SBE-β-CD) (negatively charged) and hydroxypropyl-
β-cyclodextrin (HP-β-CD) (neutral) were investigated. RH is a dopamine non-ergoline 
agonist for Parkinson’s disease therapy undergoing extensive first-pass metabolism; 
therefore might be a good candidate for buccal administration [9-12]. 
Porcine buccal mucosa, being a non-keratinized epithelium and strongly supplied with 
blood by a dense capillary vessel network, has been used as model membrane because 
its morphology and permeability are comparable to that of human buccal epithelium 
[13, 14].  Buccal permeation studies were conducted using Franz diffusion cells. 
Infrared spectroscopy (IR) was employed to investigate the interaction of permeation 
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enhancers with the epithelial lipids of porcine buccal mucosa. Finally light microscopy 
was performed to assess the histological changes resulting from the presence of the 
permeation enhancers. 
 
2. Materials and methods 
2.1 Materials 
Ropinirole HCl was kindly supplied by Pharmathen SA, Greece. Sulfobutyl ether-β-
cyclodextrin (SBE-β-CD) and hydroxypropyl-β-cyclodextrin (HP-β-CD) KLEPTOSE® 
were purchased from Roquette (Lestrem, France) Captisol® (La Jolla, USA) with MW 
2170 and 1400 g/mol respectively. Methanol (MeOH) was purchased from Chem-Lab 
NV (Belgium) and CH3COONH4 (MW 77.08) from Panreac Quimica SA (Spain). 
Buffer pH 6.8 solution simulating saliva was prepared using NaCl (0.85 g), Na2HPO4 
(0.20 g) and NaH2PO4. 2H2O (0.13 g) in 100 mL of distilled water. Phosphate buffered 
saline (PBS) pH 7.4, was prepared by dissolving NaCl (8.0g), KCl (0.20 g), Na2HPO4 
(1.44 g), and KH2PO4 (0.24 g) in 1L of distilled water. Low molecular weight (LMW, 
150 kDa, DD 95 - 98 %) chitosan was obtained from Fluka UK. Methyl iodide and 1-
methyl-2-pyrrolidinone were obtained from Across Organics, Belgium. All chemicals 
and solvents were of analytical grade and all components of buffer solutions were 
purchased from Merck (Germany). 
 
2.2 Trimethylchitosan synthesis and characterisation 
Chitosan polymer were reductively methylated to form TMC polymers with low degree 
of quaternisation according to the method of Sieval et al. [15]. Briefly chitosan (2.0 g) 
and sodium iodide (4.8 g) were dissolved in N-methyl-2-pyrrolidinone (80 mL) on a 
water bath at 60 °C under stirring. Sodium hydroxide (11 mL, 15 % w/v) and methyl 
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iodide (11.5 mL) were added when the chitosan was fully dissolved and the reaction 
was left stirring for 1 h at 60 °C in the presence of a Liebig condenser. The polymer 
products were then collected by precipitation with ethanol and ether and isolated by 
centrifugation using a Jouan B4i centrifuge (Thermo Electron Corporation, Waltham, 
USA). The products were washed twice with ethanol and diethyl ether to yield N-
trimethylchitosan iodide with a low degree of quaternisation. Ion exchange was 
undertaken by dissolving the product in sodium chloride (40 mL, 10 % w/v).  
The product was again precipitated with ethanol and diethyl ether and isolated by 
centrifugation to yield a white powder, which was subsequently dissolved in deionized 
water (40 mL) and filtered using a dialysis membrane to remove any residual sodium 
chloride. The solution was then freeze dried using a Modulyo Freeze dryer 
(Thermoelectron Corporation, Waltham, USA) to yield N-trimethyl chitosan chloride 
with low degree of quaternisation (LDQ). 
The 1H-NMR spectrum was recorded in D2O, 80 
oC with an Agilent DD2, 500 MHz 
spectrometer equipped with an NMROne probe.  
 
2.3 Tissue preparation and transport studies 
Fresh porcine mucosal specimens were obtained from a local slaughterhouse. After 
killing the animals, the tissue was immediately removed and transported to the 
laboratory in ice-cold buffer (PBS). The lag time between tissue isolation and start of 
the experiment was approximately 30 min. The specimens were surgically treated, 
using scalpel and scissors, to remove excesses of connective and adipose tissue. The 
thickness of the tissues was measured using a micrometer and the thickness of slices 
ranged from 650 to 800 μm. 
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Buccal tissues were mounted in Franz diffusion cells with a diffusion area of 4.9 cm2 
and a compartment volume of 15 mL. After an equilibration period of 10 min with PBS 
on both sides, the acceptor compartment was filled with the PBS pH 7.4 and the donor 
compartment with 5 mg/mL of RH  plain solution or in presence of 0.05 % (w/v) of the 
water-soluble enhancers [TMC (5 % w/v in water), SBE-β-CD (70 % w/v in water at 
25 o C), HP-β-CD (50 % w/v g/ in water at 25 o C)] in 1mL of PBS pH 6.8. The diffusion 
studies were carried out at 37°C, under stirring. At regular time intervals, samples of 
1mL were taken from the acceptor compartment and were replaced with the same 
amount of fresh buffer solution. Each experiment was carried out for 5 hours and results 
are reported as means of six different repetitions.  
 
2.4 Sample analysis 
Upon their collection the samples were centrifuged for 10 minutes at 12,000 rpm, the 
supernatant was collected and further evaporated to dryness by heating at 80 oC. The 
dried samples were reconstituted by adding 1mL of mobile phase. 
Drug content was quantified using an HPLC system consisting of a LC-10 AD VP 
pump, an autosampler model SIL-20A HT equipped with a 100 μL loop and a UV-Vis 
detector model SPD-10A VP (SHIMADZU) using a MZ-Analytical Kromasil C18 250 
x 4mm, 5 micrometres. UV detector was set at 250 nm for the detection of ropinirole 
hydrochloride. The mobile phase consisted of methanol-ammonium acetate 10 mM pH 
4.5 in ratio MeOH : CH3COONH4 90:10 (v/v). The adjustment of pH was done with 
1M solution of CH3COOH. Flow rate was set at 0.9 mL/min and the injection volume 
at 90 μL. The HPLC assay was performed at ambient temperature. All solvents were 
filtered through a 0.45 μm nylon membrane and degassed prior to use. The retention 
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time was 3 min. A good linearity (r2 = 0.999) was established in the range of 0.5 -10 
ppm. 
 
2.5 Analysis of permeation data 
The steady state flux (Js) across the epithelium were calculated using the following 
equation,  
Js= Q/A t (μg/cm2 hr) (1) 
where Q is the cumulative amount of drug penetrating the mucosa (μg), A is the 
diffusional area (cm2) and t is the total time of the experiment (h). 
The permeability coefficient (P) was then calculated according to the following 
equation, 
P = Js/Cd (cm/hr) (2) 
where Cd is the drug concentration in the donor compartment. 
In order to normalize the permeability data in the presence of the enhancer compared 
to control, enhancement ratios (ER) were calculated according to equation (3), 
ER = Penh/Pcontrol  (3) 
where Penh is the permeability coefficient corresponding to the enhancer treated 
epithelial tissues, and Pcontrol is the permeability coefficient respectively for the control 
(RH solution). 
 
 
 
2.6 Infrared Spectroscopy 
Infrared spectroscopy (IR) was employed to investigate the interaction of permeation 
enhancers with the epithelial lipids of porcine buccal mucosa. At the end of each 
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experiment, pieces of tissue were soaked in PBS for ca. 10 sec to rinse the enhancers 
from the mucosal surface and then placed in a dessicator for drying. Intact (untreated) 
buccal tissue epithelium was used as the control. Analysis of the samples was carried 
using a spectrophotometer ATR-FTIR (Prestige-21, SHIMADZU) in the range between 
4000 and 650 cm-1 with a resolution of 4 cm-1 after 64 scans. 
 
2.7 Histological evaluation 
Abnormalities of the mucosal architecture after drug and chemical enhancers and non-
treated buccal epithelium, were evaluated using 4 μm-thick sections of each of the 
formalin-fixed and paraffin-embedded samples stained by conventional hematoxylin-
eosin. Specimens were analysed in an Olympus CX31 optical microscope and 
microphotographs were taken via the OLYMPUS analysis getIT software. 
 
2.8 Statistical analysis 
The results are presented as mean ± standard deviation of 6 experiments. Statistical 
differences were tested using unpaired Student t-test (p<0.05). 
 
3. Results and Discussion 
3.1 Determination of degree of quartenisation 
The degree of quaternisation of TMC polymer from the 1H-NMR spectrum (Figure 1) 
was calculated from Eq. 4, 
DQ (%) = [(TM/H) x 1/9] x 100 (4) 
where DQ (%) is the degree of quaternisation expressed as a percentage, TM  is the 
integral of the trimethyl amino group (N(CH3)3) peak at 3.3 ppm and H is the integral 
of the 1H peaks between 4.7 and 5.7 ppm. From Eq.1 the degree of quaternisation of 
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chitosan was calculated at 17-18 % which is in broad agreement with previous studies 
[16].   
 
3.2 Transport studies 
Permeation profiles of plain drug and its permeation enhancement congeners, expressed 
as the cumulative amount permeated versus time, are shown in Figure 2. The steady 
state flux (Js) across the epithelium, the permeability coefficient (P) and the 
enhancement ratios are illustrated at Table 1. The cumulative amount of RH in the 
presence of TMC transported across buccal epithelium over 5 h was only 1.34-fold (t-
test p<0.05) greater compared to the control (RH solution). In the presence of SBE-β-
CD the increase of transported drug was 1.28 (t-test p<0.05) higher compared to the 
control. In a similar manner in the presence HP-β-CD the amount of RH transported 
across buccal epithelium increased 1.23 (t-test p<0.05) compared to the control 
(solution of RH). However there was no significant difference to the transported drug 
between TMC and SBE-β-CD (t-test p>0.05). The rank order effect of the permeation 
enhancers for the transport of RH across buccal epithelium was the following: TMC 
≥SBE-β-CD >HP-β-CD >RH solution.  
In a previous study the enhancing properties of TMC for the buccal delivery of a model 
macromolecular permeate (FITC-Dextran 4.4 kDa) have been attributed to partial 
dismantling of the structure of the extracellular matrix and intercellular joints which in 
turn weakens the epithelium barrier [7]. The enhanced ratios compared to the control 
in the presence of the cyclodextrins could be attributed to the fact that these 
oligosaccharides can permeate biomembranes, interacting with the lipids and increasing 
drug uptake through the epithelium [17,18].  
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3.3 Infrared spectroscopy analysis 
Although buccal mucosa represents a non-cornified epithelia, these typical CH2 bands 
have already been reported for buccal mucosa in FTIR spectra [4, 19]. Of particular 
interest are the peaks near 2854 and 2918 cm-1 (Figure 3A). After treatment with the 
enhancers, stretching vibrations were broadened but no significant shift was observed. 
The areas under the CH2 symmetric and asymmetric stretching absorbance were 
calculated as illustrated in Figure 3B. When the tissue was treated with RH and neutral 
HP-β-CD a decrease to the areas of the symmetric and asymmetric peak were observed 
compared to the control. However striking differences compared to untreated tissue 
were recorded in the presence of negatively charged SBE-β-CD and positively charged 
TMC where these peaks vanish implying alterations to epithelial lipid structure and 
organization. The enhancing action of TMC of SBE-β-CD for the transport of RH might 
be related with possible solubilization of intercellular lipids.  
 
3.4 Histopathology data 
Light microscopy was performed to assess the histological changes resulting from the 
presence of the permeation enhancers. In the histological analysis tissue specimens 
were treated with plain RH, RH/TMC, RH/SBE-β-CD and RH/HP-β-CD and were 
compared to normal oral porcine non-keratinized buccal mucosa. Specimens were 
analysed in an optical microscope (Olympus CX31). When comparing the normal 
buccal non-keratinized epithelium (Figure 4A) with the RH treated tissue, epithelial 
disarray, gap formation as well as moderate detachment of the total epithelium could 
be identified for the latter (Figure 4B). In contrast, buccal non-keratinized epithelium 
after 5h treatment with RH and TMC revealed an increase of epithelium thickness, 
epithelial detachment and mild acantholytic alterations (gaps) (Figure 4C). Previous 
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studies have shown that an increase in intercellular space and swelling is related with 
increased permeation rates of the active [4]. The current histological finding correlates 
well with the increased permeation data obtained for RH in the presence of TMC. The 
most severe epithelial damage was observed for the RH/SBE-β-CD treatment with 
intense cellular vacuolation and oedema, necrosis of superficial epithelial layers, 
intercellular gaps (spongiosis – acantholysis) and mild but clear disarray of basal layer 
of epithelial cells and subsequent detachment of epithelium from the underlying stroma 
(Figure 4D & E). Similar but less severe alterations were found in case of RH/HP-β-
CD. The latter might be attributed to the non-ionic character of HP-β-CD. The loss of 
the superficial cell layers might imply interactions between the cyclodextrins and the 
epithelial lipids given that cyclodextrins can induce lipid solubilization [20]. However 
it should be noticed that although the presence of the permeation enhancers induce 
changes to the ultrastructure of buccal epithelium, the latter are not irreversible. 
 
4. Conclusions 
The data from the current study demonstrate that the transport of RH across buccal 
epithelium is substantially increased by co-administration of permeation enhancers. 
The highest fluxes observed in the presence of the positively charged enhancer TMC 
combined with the minor structural changes to the epithelium, may be a promising 
approach to increase RH through buccal mucosa using different dosage forms (e.g. 
films, xerogels) [21,22]. Considering that buccal epithelium is permselective [23], with 
proper manipulation of the membrane, favorable conditions might be created for the 
transport of charged drugs (e.g. morphine sulfate, atenolol hydrochloride) 
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Table 1: Calculated steady state flux values (Js), permeability coefficients (P) and 
enhancement ratio for RH across porcine epithelium in the presence of permeation 
enhancers. 
 Js (μg/cm2h-1) P *10-3 (cm/h) ER 
RH 18.09 ± 2.44 3.6 ± 0.65 - 
RH/TMC 24.46 ± 2.11 4.8 ± 0.74 1.34  
RH/SBE-β-CD 22.60 ± 1.29 4.5 ± 0.25 1.28  
RH/HP-β-CD 21.40 ± 0.78 4.2 ± 0.74 1.23 
*Values are reported as mean ± standard deviation (n = 6) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 17 
FIGURE LEGENDS  
 
FIGURE 1 : 1H-NMR spectrum of N-trimethylchitosan. 
 
FIGURE 2 : Cumulative transport of RH across porcine mucosa: (▼) RH solution, 
(▲) in presence of  0.05% (w/v) TMC, (●) in presence of 0.05% (w/v) SBE-β-CD, (■) 
in presence of 0.05% (w/v) HP-β-CD. 
 
FIGURE 3 : (A) FT-IR spectra of buccal mucosa (intact), after 5h treatment with plain 
drug and its co-application with permeation enhancers, (B) Areas under CH2 
asymmetric and symmetric stretching absorbance. a: Buccal mucosa (intact), b: treated 
with RH, c:  treated with RH/HP-β-CD. 
 
FIGURE 4 : Light micrographs of A. porcine buccal mucosa with non-keratinized 
epithelium (intact), B. Light micrograph of porcine buccal mucosa after 5h treatment 
with RH. Inter-epithelial gaps (indicated by light blue arrow) and detachment of the 
epithelium from underlying stroma (black arrow) are illustrated in the micropraph C. 
Light micrograph of porcine buccal mucosa after 5h treatment with RH. Changes to the 
thickness was noticed and linear detachment of epithelium (indicated by black arrow) 
with only rare acantholysis (indicated by light blue arrow),  D & E Light micrograph 
of porcine buccal mucosa after 5h treatment with RH and SBE-β-CD led to additional 
severe epithelial damage including intense cellular vacuolation (red arrow) and 
superficial necrosis (blue arrow), F. Light micrograph of porcine buccal mucosa after 
5h treatment with RH and HP-β-CD showed similar but less severe influence to the 
epithelial structure compare to RH/SBE-β-CD treatment. (Magnification x100). 
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FIGURE 1 
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FIGURE 2 
0 1 2 3 4 50
20
40
60
80
100
120
140
160
180
200
 
 
C
u
m
u
la
ti
v
e
 a
m
o
u
n
t 
p
e
rm
e
a
te
d
  
(
g
/c
m
²)
time (h)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 20 
 
FIGURE 3 
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